Brokerages Set Astera Labs, Inc. (NASDAQ:ALAB) Price Target at $105.75

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) has earned an average rating of “Moderate Buy” from the thirteen research firms that are presently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $109.75.

Several research analysts recently issued reports on ALAB shares. Roth Mkm raised their price target on shares of Astera Labs from $80.00 to $105.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Needham & Company LLC reissued a “buy” rating and issued a $65.00 target price on shares of Astera Labs in a report on Wednesday, October 9th. Deutsche Bank Aktiengesellschaft boosted their price target on Astera Labs from $60.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Citigroup assumed coverage on Astera Labs in a research note on Monday, November 18th. They set a “buy” rating and a $120.00 price objective for the company. Finally, Morgan Stanley boosted their target price on shares of Astera Labs from $94.00 to $142.00 and gave the company an “overweight” rating in a research note on Friday, December 20th.

View Our Latest Research Report on Astera Labs

Insiders Place Their Bets

In related news, insider Sanjay Gajendra sold 740,000 shares of the firm’s stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $96.59, for a total value of $71,476,600.00. Following the transaction, the insider now owns 775,000 shares in the company, valued at $74,857,250. This trade represents a 48.84 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Stefan A. Dyckerhoff sold 50,000 shares of Astera Labs stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $89.70, for a total value of $4,485,000.00. Following the completion of the sale, the director now owns 129,617 shares of the company’s stock, valued at approximately $11,626,644.90. The trade was a 27.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,690,452 shares of company stock valued at $167,581,256.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. ORG Wealth Partners LLC bought a new stake in shares of Astera Labs during the fourth quarter worth approximately $42,000. Hollencrest Capital Management acquired a new stake in Astera Labs during the 3rd quarter worth $26,000. GAMMA Investing LLC grew its holdings in Astera Labs by 78.3% during the 4th quarter. GAMMA Investing LLC now owns 510 shares of the company’s stock worth $68,000 after acquiring an additional 224 shares during the period. US Bancorp DE bought a new stake in shares of Astera Labs during the 3rd quarter valued at $46,000. Finally, First Horizon Advisors Inc. acquired a new position in shares of Astera Labs in the 3rd quarter valued at $49,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Stock Performance

Shares of NASDAQ ALAB opened at $133.30 on Wednesday. Astera Labs has a one year low of $36.22 and a one year high of $147.39. The business has a fifty day simple moving average of $118.88 and a 200 day simple moving average of $76.01.

Astera Labs (NASDAQ:ALABGet Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.06. The firm had revenue of $113.10 million for the quarter, compared to analyst estimates of $97.50 million. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The business’s revenue for the quarter was up 47.1% compared to the same quarter last year. Analysts predict that Astera Labs will post -0.45 earnings per share for the current year.

Astera Labs Company Profile

(Get Free Report

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Read More

Analyst Recommendations for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.